Salarius Pharmaceuticals, Inc. (SLRX)
0.6605
+0.01
(+1.99%)
USD |
NASDAQ |
Dec 31, 13:13
Salarius Pharmaceuticals Research and Development Expense (Quarterly): 0.0618M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Eli Lilly & Co. | 3.466B |
| CorMedix, Inc. | 5.098M |
| Outset Medical, Inc. | 5.376M |
| Vor Biopharma, Inc. | 14.14M |
| Humacyte, Inc. | 17.27M |